Scuteri Angelo, Najjar Samer S, Muller Denis, Andres Reubin, Morrell Christopher H, Zonderman Alan B, Lakatta Edward G
Laboratory of Cardiovascular Science, NIA-NIH, 5600 Nathan Shock Dr., Baltimore, MD 21224, USA.
Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E322-7. doi: 10.1152/ajpendo.00408.2004. Epub 2005 Mar 15.
The aims of the present study were to compare the longitudinal changes in traditional cardiovascular (CV) risk factors (blood pressure, BMI, total and HDL-cholesterol, triglycerides, and blood glucose) in men with and without the apolipoprotein (apo)E4 allele. Three hundred six men from the Baltimore Longitudinal Study of Aging, ranging in age from 20 to 92 yr, were studied. Repeated measurements of CV risk factors were performed over a median follow-up time of 7 yr (maximum 14.3 yr) for men. Longitudinal changes in these CV risk factors were analyzed by linear mixed-effects models. The prevalence of the apoE4 allele was 25.5%. apoE4 was independently associated with accelerated changes over time in fasting plasma glucose (+9.5% vs. no change in those without apoE4 in the 6th age-decade over 10 yr). No significant effect of apoE4 on longitudinal changes in total or HDL-cholesterol, triglycerides, or blood pressures was observed. In conclusion, apoE4 influences fasting plasma glucose and its changes over time. This could explain, in part, the increased CV risk associated with the apoE4 genotype observed in men.
本研究的目的是比较有无载脂蛋白(apo)E4等位基因的男性传统心血管(CV)危险因素(血压、体重指数、总胆固醇和高密度脂蛋白胆固醇、甘油三酯及血糖)的纵向变化。对来自巴尔的摩纵向衰老研究的306名年龄在20至92岁之间的男性进行了研究。对男性在中位随访时间7年(最长14.3年)内重复测量CV危险因素。通过线性混合效应模型分析这些CV危险因素的纵向变化。apoE4等位基因的患病率为25.5%。apoE4与空腹血糖随时间的加速变化独立相关(在第6个年龄十年中,10年内apoE4携带者空腹血糖增加9.5%,而无apoE4者无变化)。未观察到apoE4对总胆固醇或高密度脂蛋白胆固醇、甘油三酯或血压纵向变化有显著影响。总之,apoE4影响空腹血糖及其随时间的变化。这可能部分解释了在男性中观察到的与apoE4基因型相关的心血管风险增加。